← Leaderboards
Takeshi Sano
Beth Israel Deaconess Medical Center
$815,500
Attributed
$815,500
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$815,500 · 2
By mechanism
R21$815,500 · 2
Top collaborators
No co-investigators on record.
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- Susumu Kobayashi$5,296,351
- Dezheng Zhao$3,005,725
- Vassiliki A Boussiotis$19,288,605
- Lewis C Cantley$35,988,650
- Ciaran P Kelly$9,175,834
Others in their field
Top investigators on “Tissue /Cell Culture”
- James R Gaines · University Of Hawaii At Manoa$24,999,553
- Jay B Jackson · Johns Hopkins University$22,308,100
- C Ronald Kahn · Joslin Diabetes Center$12,500,002
- George Stamatoyannopoulos · University Of Washington$11,744,799
- Laurie H Glimcher · Dana-Farber Cancer Inst$10,563,992
- Peter Karl Sorger · Massachusetts Institute Of Technology$9,821,548
Research focus
Tissue /Cell CultureTransfection /Expression VectorGene TherapyColonCrohn'S DiseaseEnzyme Linked Immunosorbent AssayEpidermal Growth FactorFlow CytometryGene Delivery SystemGene TargetingGenetically Modified AnimalsGliomaGrowth Factor ReceptorsImmunoconjugatesInflammatory Bowel DiseasesInterleukin 10Laboratory MouseMonoclonal AntibodyNeoplasm /Cancer TherapyRetroviridaeTechnology /Technique DevelopmentAngiostatinsUlcerative ColitisBiotechnology
Grant awards (4)
Safe Focused Delivery of Gene Therapeutics to Colon$255,000
R21 · FY2004 · EB
Safe Focused Delivery of Gene Therapeutics to Colon$212,500
R21 · FY2003 · EB
VIRAL VECTORS FOR TARGETED ANTI ANIOGENIC GENE THERAPY$174,000
R21 · FY2001 · CA
VIRAL VECTORS FOR TARGETED ANTI ANIOGENIC GENE THERAPY$174,000
R21 · FY2000 · CA